Drawing for ADVANSE

USPTO serial 87936976

ADVANSE

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MAIHOS, JESSIE ANDREA
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADVANSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julie Beth Albert

JULIE BETH ALBERT BAKER BOTTS L.L.P.30 ROCKEFELLER PLAZA44TH FLOORNEW YORK, NY 10112-4498

Goods and services

ClassDescriptionStatusFirst use
005A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cellsABANDONED—
010Medical devices, namely, lasers and fibre-optic wires and cables for use in photodynamic therapy with the administration of a photosensitizing agent for the treatment of cancerABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2019MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jan 23, 2019ABN5ABANDONMENT - AFTER PUBLICATION—
Jan 22, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jan 22, 2019EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Dec 25, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 25, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 5, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 16, 2018ALIEASSIGNED TO LIE—
Oct 31, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 31, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Oct 31, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 31, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 31, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 26, 2018ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 2, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2018DOCKASSIGNED TO EXAMINER—
Jun 3, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 29, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance